Esperion Therapeutics
ESPR
#7826
Rank
โ‚ฌ0.21 B
Marketcap
1,09ย โ‚ฌ
Share price
-6.59%
Change (1 day)
-61.97%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of April 2025 (TTM): 0.7680

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.6566. At the end of 2024 the company had a P/S ratio of 1.35.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.89 666.66%๐Ÿ‡บ๐Ÿ‡ธ USA
4.51 487.33%๐Ÿ‡บ๐Ÿ‡ธ USA
2.17 181.91%๐Ÿ‡บ๐Ÿ‡ธ USA
4.70 512.04%๐Ÿ‡บ๐Ÿ‡ธ USA
4.65 505.78%๐Ÿ‡บ๐Ÿ‡ธ USA
5.15 571.16%๐Ÿ‡บ๐Ÿ‡ธ USA